Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 10.75
0.186 %
$ 979 M
Market Cap
-7.62
P/E
MYGN - SHORT-TERM DEBT
Short-term Debt MYGN - Myriad Genetics, Inc.
16.2 M
LAST VALUE
11.63%
2 YEAR CAGR
-27.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR